Danish publishing firm, Ghost Ship Publishing, is back with a new title. It is partnering with a developer studio known as Chop Chop Games. The pairing has pushed out the first proper playable demo ...

Scientists say they have built a cell from scratch for the first time that can feed, grow and replicate like a natural cell. This breakthrough in synthetic biology could usher in an era of ...

For the very first time, biologists packed nonliving components into a cell-like membrane, piece by piece, and witnessed the bag of molecules start to behave like life. The lab-made synthetic cell ...

NEW ORLEANS (WVUE/Gray News) - A New Orleans man became the first person in Louisiana to be functionally cured of sickle cell disease through gene therapy. Daniel Cressy, 23, underwent the procedure ...

Test time has arrived: the first person has been treated in a highly anticipated gene therapy trial that aims to coax aged cells to take on a younger identity. The clinical trial will test a novel ...

Test time has arrived: the first person has been treated in a highly anticipated gene therapy trial that aims to coax aged cells to take on a younger identity. The clinical trial will test a novel ...

We tend to view ourselves and the complex cells that build us as a distinct branch of the tree of life from the compact, seemingly featureless cells of bacteria and archaea. But we’ve found that our ...

Cancer cells need large amounts of energy to survive and multiply. To produce that energy, they rely on structures inside the cell called mitochondria, often described as the cell's "powerhouse." ...

The really big surprises were no longer part of it when Julian Nagelsmann announced his squad for the 2026 World Cup last Thursday. Quite a few eager journalists had already “leaked” several days ...

REVO-U: A next-generation, gene-editing–free universal CAR-T platform to enable ultra–high-yield manufacturing and identification of early clinical activity in relapsed/refractory DLBCL. This is an ...

First-in-human in vivo CAR T-cell generation using a CD8-targeted lipid nanoparticle platform in relapsed/refractory B-cell lymphoma.

For the past 15 years or so, a class of drugs called immune checkpoint inhibitors have been used to treat melanoma – the most dangerous kind of skin cancer. For many patients, they produce remarkable ...